New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

We have hardly begun to understand how inextricably our own health and safety are intertwined with those of our wild ...

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

While there will no doubt be plenty of competing GLP-1 drugs and weight loss products in the market in the future ... The 10 ...

Ozempic, a drug which contains the same active ingredient of semaglutide, was approved in 2021 and subsequently included on ...